OptimizeRx (OPRX) Competitors

$5.20 +0.29 (+5.80%)

Closing price 03:59 PM Eastern

Extended Trading

$5.18 -0.02 (-0.38%)

As of 04:05 PM Eastern

OPRX vs. OOMA, ADV, IMXI, PSFE, and LTBR

Should you buy OptimizeRx stock or one of its competitors? MarketBeat compares OptimizeRx with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with OptimizeRx include Ooma (OOMA), Advantage Solutions (ADV), International Money Express (IMXI), Paysafe (PSFE), and Lightbridge (LTBR). These companies are all part of the "business services" industry.

How does OptimizeRx compare to Ooma?

OptimizeRx (NASDAQ:OPRX) and Ooma (NYSE:OOMA) are both small-cap computer and technology companies, but which is the better stock? We will contrast the two businesses based on the strength of their profitability, media sentiment, valuation, risk, dividends, analyst recommendations, institutional ownership and earnings.

Ooma has higher revenue and earnings than OptimizeRx. OptimizeRx is trading at a lower price-to-earnings ratio than Ooma, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
OptimizeRx	$107.35M	0.91	$5.13M	$0.35	14.84
Ooma	$273.60M	1.88	$6.46M	$0.22	85.09

76.5% of OptimizeRx shares are held by institutional investors. Comparatively, 80.4% of Ooma shares are held by institutional investors. 5.6% of OptimizeRx shares are held by company insiders. Comparatively, 9.9% of Ooma shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

In the previous week, OptimizeRx had 8 more articles in the media than Ooma. MarketBeat recorded 12 mentions for OptimizeRx and 4 mentions for Ooma. OptimizeRx's average media sentiment score of 0.48 beat Ooma's score of 0.30 indicating that OptimizeRx is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
OptimizeRx	1 Very Positive mention(s)	1 Positive mention(s)	5 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral
Ooma	1 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

OptimizeRx presently has a consensus target price of $13.43, suggesting a potential upside of 158.49%. Ooma has a consensus target price of $19.00, suggesting a potential upside of 1.50%. Given OptimizeRx's higher probable upside, research analysts plainly believe OptimizeRx is more favorable than Ooma.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
OptimizeRx	1 Sell rating(s)	2 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.56
Ooma	0 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.67

OptimizeRx has a net margin of 6.37% compared to Ooma's net margin of 2.36%. Ooma's return on equity of 15.60% beat OptimizeRx's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
OptimizeRx	6.37%	11.00%	7.88%
Ooma	2.36%	15.60%	8.24%

OptimizeRx has a beta of 1.19, suggesting that its stock price is 19% more volatile than the broader market. Comparatively, Ooma has a beta of 1.2, suggesting that its stock price is 20% more volatile than the broader market.

Summary

Ooma beats OptimizeRx on 10 of the 16 factors compared between the two stocks.

How does OptimizeRx compare to Advantage Solutions?

OptimizeRx (NASDAQ:OPRX) and Advantage Solutions (NASDAQ:ADV) are both small-cap business services companies, but which is the superior business? We will compare the two businesses based on the strength of their profitability, institutional ownership, earnings, valuation, media sentiment, dividends, analyst recommendations and risk.

OptimizeRx has a beta of 1.19, suggesting that its share price is 19% more volatile than the broader market. Comparatively, Advantage Solutions has a beta of 2.21, suggesting that its share price is 121% more volatile than the broader market.

OptimizeRx currently has a consensus target price of $13.43, indicating a potential upside of 158.49%. Advantage Solutions has a consensus target price of $34.38, indicating a potential upside of 0.53%. Given OptimizeRx's stronger consensus rating and higher probable upside, equities research analysts clearly believe OptimizeRx is more favorable than Advantage Solutions.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
OptimizeRx	1 Sell rating(s)	2 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.56
Advantage Solutions	1 Sell rating(s)	2 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

OptimizeRx has higher earnings, but lower revenue than Advantage Solutions. Advantage Solutions is trading at a lower price-to-earnings ratio than OptimizeRx, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
OptimizeRx	$107.35M	0.91	$5.13M	$0.35	14.84
Advantage Solutions	$3.54B	0.13	-$227.74M	-$18.74	N/A

In the previous week, OptimizeRx had 4 more articles in the media than Advantage Solutions. MarketBeat recorded 12 mentions for OptimizeRx and 8 mentions for Advantage Solutions. Advantage Solutions' average media sentiment score of 1.01 beat OptimizeRx's score of 0.48 indicating that Advantage Solutions is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
OptimizeRx	1 Very Positive mention(s)	1 Positive mention(s)	5 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral
Advantage Solutions	2 Very Positive mention(s)	5 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

76.5% of OptimizeRx shares are held by institutional investors. Comparatively, 49.8% of Advantage Solutions shares are held by institutional investors. 5.6% of OptimizeRx shares are held by company insiders. Comparatively, 9.4% of Advantage Solutions shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

OptimizeRx has a net margin of 6.37% compared to Advantage Solutions' net margin of -6.78%. OptimizeRx's return on equity of 11.00% beat Advantage Solutions' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
OptimizeRx	6.37%	11.00%	7.88%
Advantage Solutions	-6.78%	-37.22%	-7.93%

Summary

OptimizeRx beats Advantage Solutions on 12 of the 16 factors compared between the two stocks.

How does OptimizeRx compare to International Money Express?

International Money Express (NASDAQ:IMXI) and OptimizeRx (NASDAQ:OPRX) are both small-cap business services companies, but which is the superior business? We will compare the two companies based on the strength of their risk, analyst recommendations, valuation, profitability, dividends, earnings, media sentiment and institutional ownership.

OptimizeRx has a net margin of 6.37% compared to International Money Express' net margin of 4.34%. International Money Express' return on equity of 23.26% beat OptimizeRx's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
International Money Express	4.34%	23.26%	6.88%
OptimizeRx	6.37%	11.00%	7.88%

In the previous week, OptimizeRx had 8 more articles in the media than International Money Express. MarketBeat recorded 12 mentions for OptimizeRx and 4 mentions for International Money Express. OptimizeRx's average media sentiment score of 0.48 beat International Money Express' score of 0.18 indicating that OptimizeRx is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
International Money Express	1 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
OptimizeRx	1 Very Positive mention(s)	1 Positive mention(s)	5 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral

OptimizeRx has a consensus target price of $13.43, suggesting a potential upside of 158.49%. Given OptimizeRx's stronger consensus rating and higher probable upside, analysts plainly believe OptimizeRx is more favorable than International Money Express.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
International Money Express	1 Sell rating(s)	2 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.67
OptimizeRx	1 Sell rating(s)	2 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.56

International Money Express has higher revenue and earnings than OptimizeRx. International Money Express is trading at a lower price-to-earnings ratio than OptimizeRx, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
International Money Express	$607.78M	0.75	$32.67M	$1.08	14.08
OptimizeRx	$107.35M	0.91	$5.13M	$0.35	14.84

86.7% of International Money Express shares are owned by institutional investors. Comparatively, 76.5% of OptimizeRx shares are owned by institutional investors. 5.1% of International Money Express shares are owned by insiders. Comparatively, 5.6% of OptimizeRx shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

International Money Express has a beta of 0.78, meaning that its share price is 22% less volatile than the broader market. Comparatively, OptimizeRx has a beta of 1.19, meaning that its share price is 19% more volatile than the broader market.

Summary

OptimizeRx beats International Money Express on 10 of the 16 factors compared between the two stocks.

How does OptimizeRx compare to Paysafe?

Paysafe (NYSE:PSFE) and OptimizeRx (NASDAQ:OPRX) are both small-cap business services companies, but which is the better investment? We will contrast the two businesses based on the strength of their valuation, dividends, earnings, media sentiment, risk, institutional ownership, profitability and analyst recommendations.

Paysafe currently has a consensus price target of $10.96, indicating a potential upside of 34.03%. OptimizeRx has a consensus price target of $13.43, indicating a potential upside of 158.49%. Given OptimizeRx's stronger consensus rating and higher possible upside, analysts clearly believe OptimizeRx is more favorable than Paysafe.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Paysafe	2 Sell rating(s)	4 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	1.86
OptimizeRx	1 Sell rating(s)	2 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.56

OptimizeRx has a net margin of 6.37% compared to Paysafe's net margin of -10.73%. Paysafe's return on equity of 11.55% beat OptimizeRx's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Paysafe	-10.73%	11.55%	1.83%
OptimizeRx	6.37%	11.00%	7.88%

In the previous week, Paysafe had 2 more articles in the media than OptimizeRx. MarketBeat recorded 14 mentions for Paysafe and 12 mentions for OptimizeRx. Paysafe's average media sentiment score of 0.56 beat OptimizeRx's score of 0.48 indicating that Paysafe is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Paysafe	4 Very Positive mention(s)	2 Positive mention(s)	4 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive
OptimizeRx	1 Very Positive mention(s)	1 Positive mention(s)	5 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral

54.4% of Paysafe shares are owned by institutional investors. Comparatively, 76.5% of OptimizeRx shares are owned by institutional investors. 5.6% of OptimizeRx shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

OptimizeRx has lower revenue, but higher earnings than Paysafe. Paysafe is trading at a lower price-to-earnings ratio than OptimizeRx, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Paysafe	$1.70B	0.25	-$182.51M	-$3.15	N/A
OptimizeRx	$107.35M	0.91	$5.13M	$0.35	14.84

Paysafe has a beta of 1.82, suggesting that its stock price is 82% more volatile than the broader market. Comparatively, OptimizeRx has a beta of 1.19, suggesting that its stock price is 19% more volatile than the broader market.

Summary

OptimizeRx beats Paysafe on 11 of the 16 factors compared between the two stocks.

How does OptimizeRx compare to Lightbridge?

OptimizeRx (NASDAQ:OPRX) and Lightbridge (NASDAQ:LTBR) are both small-cap business services companies, but which is the superior business? We will compare the two companies based on the strength of their risk, profitability, dividends, media sentiment, institutional ownership, valuation, earnings and analyst recommendations.

OptimizeRx has a beta of 1.19, suggesting that its share price is 19% more volatile than the broader market. Comparatively, Lightbridge has a beta of 2.18, suggesting that its share price is 118% more volatile than the broader market.

OptimizeRx presently has a consensus price target of $13.43, indicating a potential upside of 158.49%. Given OptimizeRx's stronger consensus rating and higher possible upside, research analysts clearly believe OptimizeRx is more favorable than Lightbridge.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
OptimizeRx	1 Sell rating(s)	2 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.56
Lightbridge	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

76.5% of OptimizeRx shares are owned by institutional investors. Comparatively, 9.1% of Lightbridge shares are owned by institutional investors. 5.6% of OptimizeRx shares are owned by company insiders. Comparatively, 5.4% of Lightbridge shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

OptimizeRx has higher revenue and earnings than Lightbridge. Lightbridge is trading at a lower price-to-earnings ratio than OptimizeRx, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
OptimizeRx	$107.35M	0.91	$5.13M	$0.35	14.84
Lightbridge	N/A	N/A	-$19.58M	-$0.77	N/A

In the previous week, OptimizeRx had 10 more articles in the media than Lightbridge. MarketBeat recorded 12 mentions for OptimizeRx and 2 mentions for Lightbridge. Lightbridge's average media sentiment score of 0.93 beat OptimizeRx's score of 0.48 indicating that Lightbridge is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
OptimizeRx	1 Very Positive mention(s)	1 Positive mention(s)	5 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral
Lightbridge	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

OptimizeRx has a net margin of 6.37% compared to Lightbridge's net margin of 0.00%. OptimizeRx's return on equity of 11.00% beat Lightbridge's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
OptimizeRx	6.37%	11.00%	7.88%
Lightbridge	N/A	-12.59%	-12.50%

Summary

OptimizeRx beats Lightbridge on 13 of the 15 factors compared between the two stocks.

Get OptimizeRx News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding OPRX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

OPRX vs. The Competition

Export

Metric	OptimizeRx	COMP Industry	Computer Sector	NASDAQ Exchange
Market Cap	$97.48M	$143.29B	$39.48B	$12.46B
Dividend Yield	N/A	1.96%	3.20%	5.30%
P/E Ratio	14.84	19.59	163.79	25.61
Price / Sales	0.91	5.00	623.36	63.45
Price / Cash	6.44	17.21	47.82	55.34
Price / Book	0.76	26.44	9.57	6.71
Net Income	$5.13M	$5.11B	$1.03B	$333.77M
7 Day Performance	-21.64%	-5.66%	0.36%	0.40%
1 Month Performance	-14.13%	1.91%	9.57%	4.03%
1 Year Performance	-48.62%	-21.28%	164.76%	36.33%

OptimizeRx Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
OPRX OptimizeRx	4.4007 of 5 stars	$5.20 +5.8%	$13.43 +158.5%	-55.4%	$97.48M	$107.35M	14.84	100	Earnings Report Analyst Forecast Gap Up High Trading Volume
OOMA Ooma	2.2265 of 5 stars	$18.12 +2.2%	$19.00 +4.8%	+41.5%	$495.62M	$273.60M	81.89	1,420
ADV Advantage Solutions	2.169 of 5 stars	$36.81 -0.4%	$28.13 -23.6%	+23.7%	$480.18M	$3.54B	N/A	73,000	Positive News
IMXI International Money Express	1.7416 of 5 stars	$15.92 -0.2%	$11.50 -27.7%	+31.9%	$479.68M	$607.78M	14.74	1,303	Earnings Report Analyst Downgrade
PSFE Paysafe	4.2972 of 5 stars	$9.09 -3.4%	$9.81 +7.9%	-32.3%	$470.65M	$1.70B	N/A	2,900	Trending News Earnings Report Analyst Forecast

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:OPRX) was last updated on 5/14/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

OptimizeRx (OPRX) Competitors

OPRX vs. OOMA, ADV, IMXI, PSFE, and LTBR

How does OptimizeRx compare to Ooma?

Summary

How does OptimizeRx compare to Advantage Solutions?

Summary

How does OptimizeRx compare to International Money Express?

Summary

How does OptimizeRx compare to Paysafe?

Summary

How does OptimizeRx compare to Lightbridge?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

OPRX vs. The Competition

OptimizeRx Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

OptimizeRx (OPRX) Competitors

OPRX vs. OOMA, ADV, IMXI, PSFE, and LTBR

How does OptimizeRx compare to Ooma?

Which has higher earnings and valuation, OPRX or OOMA?

Do insiders & institutionals hold more shares of OPRX or OOMA?

Does the media prefer OPRX or OOMA?

Do analysts rate OPRX or OOMA?

Is OPRX or OOMA more profitable?

Which has more risk & volatility, OPRX or OOMA?

Summary

How does OptimizeRx compare to Advantage Solutions?

Which has more volatility & risk, OPRX or ADV?

Do analysts rate OPRX or ADV?

Which has stronger valuation & earnings, OPRX or ADV?

Does the media refer more to OPRX or ADV?

Do institutionals and insiders believe in OPRX or ADV?

Is OPRX or ADV more profitable?

Summary

How does OptimizeRx compare to International Money Express?

Is IMXI or OPRX more profitable?

Does the media favor IMXI or OPRX?

Do analysts recommend IMXI or OPRX?

Which has stronger earnings & valuation, IMXI or OPRX?

Do insiders & institutionals hold more shares of IMXI or OPRX?

Which has more volatility and risk, IMXI or OPRX?

Summary

How does OptimizeRx compare to Paysafe?

Do analysts rate PSFE or OPRX?

Is PSFE or OPRX more profitable?

Does the media favor PSFE or OPRX?

Do institutionals & insiders hold more shares of PSFE or OPRX?

Which has higher earnings and valuation, PSFE or OPRX?

Which has more risk & volatility, PSFE or OPRX?

Summary

How does OptimizeRx compare to Lightbridge?

Which has more risk and volatility, OPRX or LTBR?

Do analysts recommend OPRX or LTBR?

Do insiders and institutionals believe in OPRX or LTBR?

Which has stronger earnings & valuation, OPRX or LTBR?

Does the media favor OPRX or LTBR?

Is OPRX or LTBR more profitable?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

OPRX vs. The Competition

OptimizeRx Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools